Technology in dementia | Technology limitations and acceptance in dementia | Quality of life | Therapeutic methods | Additional comments | |
Astell et al33 | X | ||||
Boyd et al23 | X | ||||
Brod et al24 | X | ||||
Clarkson et al1 | X | X | |||
Cook et al9 | X | X | |||
Czarnuch et al8 | X | X | |||
Day Clock26 | X | ||||
Dua et al19 | Used in the introduction for providing information around the WHO’s action plan | ||||
Fleming and Sum17 | X | ||||
Gibson et al36 | X | ||||
Gibson et al22 | X | ||||
Glaser and Salzberg2 | Used in the introduction for providing information on the wider use of technology in healthcare | ||||
Greenhalgh et al4 | Used in the introduction for providing information on the wider expectation of technology in healthcare | ||||
Hopkins28 | X | ||||
Huldtgren et al30 | X | X | |||
Impact on Carers7 | Used in the introduction to provide statistics on the impact of dementia | ||||
iSupport20 | X | ||||
Jamieson et al25 | X | ||||
Kasl-Godley and Gatz35 | X | X | |||
Kim et al31 | X | X | X | ||
Lawton15 | X | ||||
Lawton et al18 | X | X | |||
Leroi et al37 | X | ||||
Liu et al38 | X | X | |||
Logsdon et al13 | X | X | |||
MagiPlug29 | X | ||||
Marshall21 | X | X | |||
Moher et al10 | Used for the PRISMA framework for search results | ||||
Murphy et al32 | X | ||||
Nair and Dreyfus3 | Used in the introduction for providing information on the wider limitations of technology in healthcare | ||||
Pivotell27 | X | ||||
Ready and Ott14 | X | ||||
Revell et al12 | X | ||||
Robinson et al11 | X | X | |||
WHO16 | X | ||||
Woods et al6 | X | X | |||
WHO5 | X | X | |||
Zheng et al34 | X |
PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses.